Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMF vs Goserelin + Tamoxifen in Premenopausal HR+ Early Breast Cancer
NCT00309478Phase 3Completed
- Sponsor
- Austrian Breast and Colorectal Cancer Study Group
- Start
- Dec 1990
- Primary completion
- Jun 2004
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 3 trial of goserelin, tamoxifen in breast cancer, sponsored by Austrian Breast and Colorectal Cancer Study Group. Started Dec 1990; status: completed.
02
Drugs
goserelintamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00309478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309478.